[go: up one dir, main page]

SE9904581D0 - A novel helicobacter pylori-binding substance and use thereof - Google Patents

A novel helicobacter pylori-binding substance and use thereof

Info

Publication number
SE9904581D0
SE9904581D0 SE9904581A SE9904581A SE9904581D0 SE 9904581 D0 SE9904581 D0 SE 9904581D0 SE 9904581 A SE9904581 A SE 9904581A SE 9904581 A SE9904581 A SE 9904581A SE 9904581 D0 SE9904581 D0 SE 9904581D0
Authority
SE
Sweden
Prior art keywords
helicobacter pylori
binding substance
novel helicobacter
binding
identification
Prior art date
Application number
SE9904581A
Other languages
English (en)
Inventor
Karl-Anders Karlsson
Irene Leonardsson
Susann Teneberg
Jonas Aangstroem
Original Assignee
A & Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Invest Ab filed Critical A & Science Invest Ab
Priority to SE9904581A priority Critical patent/SE9904581D0/sv
Publication of SE9904581D0 publication Critical patent/SE9904581D0/sv
Priority to CA002392766A priority patent/CA2392766A1/en
Priority to JP2001544888A priority patent/JP2003517015A/ja
Priority to EEP200200312A priority patent/EE200200312A/xx
Priority to SK815-2002A priority patent/SK8152002A3/sk
Priority to PL00356329A priority patent/PL356329A1/xx
Priority to US10/149,608 priority patent/US20040086514A1/en
Priority to CNB008172927A priority patent/CN100389773C/zh
Priority to AU24188/01A priority patent/AU783876B2/en
Priority to RU2002118703/15A priority patent/RU2283115C2/ru
Priority to IL15024700A priority patent/IL150247A0/xx
Priority to NZ520111A priority patent/NZ520111A/en
Priority to PCT/SE2000/002567 priority patent/WO2001043751A1/en
Priority to EP00987920A priority patent/EP1237558A1/en
Priority to CZ20021989A priority patent/CZ20021989A3/cs
Priority to HU0204243A priority patent/HUP0204243A3/hu
Priority to ZA200204251A priority patent/ZA200204251B/en
Priority to NO20022890A priority patent/NO20022890L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE9904581A 1999-12-15 1999-12-15 A novel helicobacter pylori-binding substance and use thereof SE9904581D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE9904581A SE9904581D0 (sv) 1999-12-15 1999-12-15 A novel helicobacter pylori-binding substance and use thereof
HU0204243A HUP0204243A3 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
AU24188/01A AU783876B2 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
IL15024700A IL150247A0 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
EEP200200312A EE200200312A (et) 1999-12-15 2000-12-15 Uued Helicobacter pylori'ga seonduvad ained ja nende kasutamine
SK815-2002A SK8152002A3 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
PL00356329A PL356329A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
US10/149,608 US20040086514A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
CNB008172927A CN100389773C (zh) 1999-12-15 2000-12-15 新的能结合幽门螺杆菌的物质及其用途
CA002392766A CA2392766A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
RU2002118703/15A RU2283115C2 (ru) 1999-12-15 2000-12-15 Новые вещества, связывающиеся с helicobacter pylori, и их применение
JP2001544888A JP2003517015A (ja) 1999-12-15 2000-12-15 ヘリコバクターピロリ結合性新規物質およびその用途
NZ520111A NZ520111A (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
PCT/SE2000/002567 WO2001043751A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
EP00987920A EP1237558A1 (en) 1999-12-15 2000-12-15 Novel helicobacter pylori-binding substances and use thereof
CZ20021989A CZ20021989A3 (cs) 1999-12-15 2000-12-15 Látka, která váľe Helicobacter pylori, farmaceutický prostředek je obsahující a její pouľití
ZA200204251A ZA200204251B (en) 1999-12-15 2002-05-28 Novel helicobacter pylori-binding substances and use thereof.
NO20022890A NO20022890L (no) 1999-12-15 2002-06-17 Nye Heliobacter pylori-bindende substanser samt anvendelse derav

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904581A SE9904581D0 (sv) 1999-12-15 1999-12-15 A novel helicobacter pylori-binding substance and use thereof

Publications (1)

Publication Number Publication Date
SE9904581D0 true SE9904581D0 (sv) 1999-12-15

Family

ID=20418126

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904581A SE9904581D0 (sv) 1999-12-15 1999-12-15 A novel helicobacter pylori-binding substance and use thereof

Country Status (18)

Country Link
US (1) US20040086514A1 (sv)
EP (1) EP1237558A1 (sv)
JP (1) JP2003517015A (sv)
CN (1) CN100389773C (sv)
AU (1) AU783876B2 (sv)
CA (1) CA2392766A1 (sv)
CZ (1) CZ20021989A3 (sv)
EE (1) EE200200312A (sv)
HU (1) HUP0204243A3 (sv)
IL (1) IL150247A0 (sv)
NO (1) NO20022890L (sv)
NZ (1) NZ520111A (sv)
PL (1) PL356329A1 (sv)
RU (1) RU2283115C2 (sv)
SE (1) SE9904581D0 (sv)
SK (1) SK8152002A3 (sv)
WO (1) WO2001043751A1 (sv)
ZA (1) ZA200204251B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20010118A7 (sv) * 2001-01-19 2002-07-20 Carbion Oy Nya receptorer för helicobacter pylori och deras användning
ATE429233T1 (de) * 2001-06-29 2009-05-15 Glykos Finland Oy Verwendung mindestens einer glycoinhibitor- substanz gegen infektionskrankheiten
FI20011403A7 (sv) * 2001-06-29 2002-12-30 Carbion Oy Förfarande och sammansättningar för behandling av magsjukdomar
JP2005526711A (ja) * 2002-01-18 2005-09-08 バイオティ セラピィーズ コープ ヘリコバクターピロリに対する新規結合エピトープおよびその用途
ATE305309T1 (de) * 2002-02-04 2005-10-15 Kyowa Hakko Kogyo Kk Pharmazeutische und lebenmittelzusammensetzungen mit einem di- oder oligosaccharid, das die insulinfreisetzung steigert
EP1531832B1 (en) * 2002-06-28 2009-04-15 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
FI20021989A0 (sv) * 2002-11-06 2002-11-06 Halina Miller-Podraza Receptorer för Helicobacter pylori med hög affinitet och deras användning
US20080274557A1 (en) * 2005-03-03 2008-11-06 Indiana University Research And Technology Permethylation Of Oligosaccharides
JP4677525B2 (ja) * 2005-08-23 2011-04-27 国立大学法人 長崎大学 ヘリコバクター・ピロリの空胞化毒素の検出試薬および検出方法
FR2906808B1 (fr) * 2006-10-10 2012-10-05 Univ Nantes Utilisation d'anticorps monoclonaux specifiques de la forme o-acetylee du ganglioside gd2 dans le traitement de certains cancers
JP5014018B2 (ja) * 2006-10-18 2012-08-29 旭化成ケミカルズ株式会社 ピロリ菌の抑制剤または静菌剤
US20090054355A1 (en) * 2007-01-12 2009-02-26 Shinshu University Proliferation Inhibitor Of Helicobacter Pylori Including Alpha-N-Acetyl-Glucosaminyl Bond-Containing Monosaccharide Derivatives
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
GB0817908D0 (en) * 2008-10-01 2008-11-05 Univ Ghent Blood group a/b/h determinant on type 1 core glycosphinglipids chain as recognition point for the fedf protein of f18-fimbriated enterotoxigenic
JP5383692B2 (ja) * 2008-10-10 2014-01-08 公益財団法人野口研究所 ピロリ菌増殖抑制剤
EP2844301A2 (en) * 2012-05-04 2015-03-11 Ineb-instituto de Engenharia Biomédica Microspheres for treating helicobacter pylori infections

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
EP0058665B1 (en) * 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
US4678747A (en) * 1983-02-18 1987-07-07 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies for detection of an H (O) blood group antigen
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
US4971905A (en) * 1987-08-11 1990-11-20 Pacific Northwest Research Foundation Diagnosis of cancerous or precancerous conditions in human secretory epithelia by enzyme activity of β-1-3N-acetylglucosaminyltransferase
US4895838A (en) * 1988-03-09 1990-01-23 Trustees Of Boston University Method for provoking angiogenesis by administration of angiogenically active oligosaccharides
US4957741A (en) * 1988-08-02 1990-09-18 Angio-Medical Corp. Method for the treatment of gastric ulcer
US5877028A (en) * 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
EP0601417A3 (de) * 1992-12-11 1998-07-01 Hoechst Aktiengesellschaft Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung
US6406894B1 (en) * 1992-12-11 2002-06-18 Glycorex Ab Process for preparing polyvalent and physiologically degradable carbohydrate-containing polymers by enzymatic glycosylation reactions and the use thereof for preparing carbohydrate building blocks
US6300113B1 (en) * 1995-11-21 2001-10-09 New England Biolabs Inc. Isolation and composition of novel glycosidases
DE4408248A1 (de) * 1994-03-11 1995-09-14 Hoechst Ag Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung
US5679769A (en) * 1994-03-15 1997-10-21 Sloan-Kettering Institute For Cancer Research Synthesis of asparagine-linked glycopeptides on a polymeric solid support
CA2189356A1 (en) * 1994-05-02 1995-11-09 Ting Chi Wong Process for preparation of glycosides of tumor-associated carbohydrate antigens
CZ89098A3 (cs) * 1995-09-29 1998-09-16 Glycim Oy Syntetické polylaktosaminy obsahující až multivalentní sLEX a metody pro jejich použití
DE69737496D1 (de) * 1996-01-30 2007-05-03 Glycomimetics Inc SIALYL-LEWISa UND SIALYL LEWISx EPITOP-ANALOGE
US6841543B1 (en) * 1996-01-31 2005-01-11 President And Fellows Of Harvard College Methods of inhibiting production of T helper type 2 cytokines in human immune cells
WO1997047646A1 (en) * 1996-06-10 1997-12-18 Boren Thomas Helicobacter pylori adhesin binding group antigen
CA2261877C (en) * 1996-07-23 2009-04-07 Seikagaku Corporation Novel lactosamine oligosaccharide and method for producing the same
JPH1045602A (ja) * 1996-07-31 1998-02-17 Motoyasu Murakami ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤
US6902903B1 (en) * 1996-12-19 2005-06-07 Chiron Corporation Helicobacter pylori diagnostics
US6410057B1 (en) * 1997-12-12 2002-06-25 Samyang Corporation Biodegradable mixed polymeric micelles for drug delivery
AR018528A1 (es) * 1997-12-12 2001-11-28 Expression Genetics Inc Mezcla polimerica biodegradable de micelas para transferencia genetica
JP4318765B2 (ja) * 1998-04-01 2009-08-26 雪印乳業株式会社 ピロリ菌感染防御剤
KR100460173B1 (ko) * 1998-12-11 2004-12-04 겐 코오포레이션 헬리코박터 파일로리 정착 억제제
US20010051349A1 (en) * 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US20030100508A1 (en) * 1999-02-24 2003-05-29 Maryline Simon Carbohydrate epitope mimic compounds and uses thereof
CN1402786A (zh) * 1999-05-18 2003-03-12 衣阿华研究基金大学 复合糖的生产
AUPQ275799A0 (en) * 1999-09-10 1999-10-07 Luminis Pty Limited Recombinant bacterium expressing an oligosaccharide receptor mimic
FI19992070A7 (sv) * 1999-09-28 2001-03-29 Carbion Oy Nya fukosylerade oligosackarider och förfarande för deras framställning
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20010118A7 (sv) * 2001-01-19 2002-07-20 Carbion Oy Nya receptorer för helicobacter pylori och deras användning
EP1417965A1 (en) * 2002-11-07 2004-05-12 Vereniging Voor Christelijk Wetenschappelijk Onderwijs C-type lectin binding molecules, identification and uses thereof
CN1997392B (zh) * 2004-05-11 2011-06-01 荷兰健康、福利与体育部部长代表的荷兰国 作为佐剂的脑膜炎奈瑟氏菌lgtB LOS
AU2005327199A1 (en) * 2004-07-09 2006-08-17 Amaox, Inc. Immune cell biosensors and methods of using same
WO2006093524A2 (en) * 2004-07-16 2006-09-08 The General Hospital Corporation Antigen-carbohydrate conjugates

Also Published As

Publication number Publication date
CN1411376A (zh) 2003-04-16
NZ520111A (en) 2004-08-27
RU2002118703A (ru) 2004-02-20
JP2003517015A (ja) 2003-05-20
EE200200312A (et) 2003-06-16
ZA200204251B (en) 2003-05-28
CN100389773C (zh) 2008-05-28
RU2283115C2 (ru) 2006-09-10
AU783876B2 (en) 2005-12-15
CA2392766A1 (en) 2001-06-21
AU2418801A (en) 2001-06-25
HUP0204243A3 (en) 2003-08-28
SK8152002A3 (en) 2002-11-06
PL356329A1 (en) 2004-06-28
HUP0204243A2 (hu) 2003-03-28
EP1237558A1 (en) 2002-09-11
CZ20021989A3 (cs) 2002-10-16
WO2001043751A1 (en) 2001-06-21
US20040086514A1 (en) 2004-05-06
NO20022890D0 (no) 2002-06-17
NO20022890L (no) 2002-08-15
IL150247A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
SE9904581D0 (sv) A novel helicobacter pylori-binding substance and use thereof
RU2159761C2 (ru) Замещенные 4-биарилмасляные или 5-биарилпентановые кислоты или их производные, способы их получения, фармацевтическая композиция и способ лечения
BR0309546A (pt) Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii
BRPI0409969A (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
ATE271060T1 (de) Verbindungen und pharmazeutische zusammensetzungen zur behandlung und prophylaxe bakterieller infektionen
EP1140840A4 (en) -G (V) -CARBOXYARYL SUBSTITUTED DIPHENYL UREASINE AS RAF KINASE INHIBITORS
BG102708A (en) 4-aminopyrimidine derivatives, medicamentous preparations containing them, their application and method for their preparation
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
DK1041072T3 (da) Dioxocyclopentylhydroxamsyrer
BR0001292A (pt) Desfolhante
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
WO2001010894A3 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
SG114627A1 (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
EE200300064A (et) Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
DK1207870T3 (da) Farmaceutiske præparater, der indeholder N-palmitoylethanolamid og anvendelse deraf
NO20013787D0 (no) Soyaekstrakt som inneholder lipider, fremgangsmåte for dets fremstilling og farmasöytiske og kosmetiske blandinger
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
ATE402158T1 (de) Flavonoid-derivat
BRPI0411245A (pt) composto, composição farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de vìrus oncogênicos e para tratamento ou profilaxia de condições ou distúrbios devidos a infecção por hpv
TW200504051A (en) Novel acridine derivatives and their use as medicaments
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
WO2001014576A8 (en) Process and intermediates for the preparation of isoxazolecaroxamides and analogues
CY1108781T1 (el) Εμβολιο ψαριων
CL2004001461A1 (es) Compuestos derivados de 1,2,3,4-tetrahidropirimidina, composicion farmaceutica y su procedimiento de preparacion, procedimiento de preparacion, utiles para tratar o prevenir la hepatitis c.